| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Digital Trooper Inc is a Website Security & Charlotte Web/iPad/iPhone/Android Development company. Need CMS, Email Marketing, Mobile App Dev, SEO, Social Media?
Adventure Tech is a Overland Park, KS-based company in the Software and Internet sector.
Nexgen Solutions is a Medford, NJ-based company in the Software and Internet sector.
Jyve is a fast growing technology company that serves the largest brands and retailers in the world.